Krishnan Mahesh
SEC Form 4 insider trading activity
Krishnan Mahesh has filed 2 SEC Form 4 filings (3 transaction rows) across 1 company, with disclosures dating back to 2026. 2 of those filings fall inside the rolling window. Most recent filing: Jun 30, 2026.
On the most recent filing, Krishnan Mahesh is listed as Director at HALOZYME THERAPEUTICS, INC. Inside the rolling window, Krishnan Mahesh reported no open-market purchases and 1 open-market sale totaling $548K in HALO.
Companies traded
Other insiders at HALO
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$548K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Krishnan Mahesh made?
Krishnan Mahesh has filed 2 SEC Form 4 filings (3 transaction rows) across 1 company since 2026.
Which companies does Krishnan Mahesh trade?
Krishnan Mahesh has filed SEC Form 4 disclosures for 1 company, including HALO.
When was Krishnan Mahesh's most recent SEC Form 4 filing?
Krishnan Mahesh's most recent SEC Form 4 filing on Tracefour is dated Jun 30, 2026.
What is Krishnan Mahesh's total buy and sell value in the current window?
Inside the rolling retention window, Krishnan Mahesh bought $0 and sold $548K based on SEC Form 4 filings.
What was Krishnan Mahesh's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 7,304 HALO shares on 2026-06-29, worth $548K, per SEC Form 4 filings.